HUTCHMED (HCM) Competitors $17.66 -0.12 (-0.65%) As of 01:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCM vs. MRNA, RDY, QGEN, VTRS, ASND, VRNA, BBIO, BPMC, ROIV, and LEGNShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Moderna (MRNA), Dr. Reddy's Laboratories (RDY), QIAGEN (QGEN), Viatris (VTRS), Ascendis Pharma A/S (ASND), Verona Pharma PLC American Depositary Share (VRNA), BridgeBio Pharma (BBIO), Blueprint Medicines (BPMC), Roivant Sciences (ROIV), and Legend Biotech (LEGN). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Its Competitors Moderna Dr. Reddy's Laboratories QIAGEN Viatris Ascendis Pharma A/S Verona Pharma PLC American Depositary Share BridgeBio Pharma Blueprint Medicines Roivant Sciences Legend Biotech Moderna (NASDAQ:MRNA) and HUTCHMED (NASDAQ:HCM) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations. Is MRNA or HCM more profitable? HUTCHMED has a net margin of 0.00% compared to Moderna's net margin of -105.67%. HUTCHMED's return on equity of 0.00% beat Moderna's return on equity.Company Net Margins Return on Equity Return on Assets Moderna-105.67% -28.69% -21.94% HUTCHMED N/A N/A N/A Does the media favor MRNA or HCM? In the previous week, Moderna had 9 more articles in the media than HUTCHMED. MarketBeat recorded 12 mentions for Moderna and 3 mentions for HUTCHMED. HUTCHMED's average media sentiment score of 1.16 beat Moderna's score of 0.16 indicating that HUTCHMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Moderna 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HUTCHMED 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, MRNA or HCM? HUTCHMED has lower revenue, but higher earnings than Moderna. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioModerna$3.24B4.07-$3.56B-$8.73-3.90HUTCHMED$630.20M4.89$37.73MN/AN/A Do institutionals and insiders hold more shares of MRNA or HCM? 75.3% of Moderna shares are owned by institutional investors. Comparatively, 8.8% of HUTCHMED shares are owned by institutional investors. 11.0% of Moderna shares are owned by company insiders. Comparatively, 3.6% of HUTCHMED shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more volatility and risk, MRNA or HCM? Moderna has a beta of 1.84, suggesting that its share price is 84% more volatile than the S&P 500. Comparatively, HUTCHMED has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500. Do analysts recommend MRNA or HCM? Moderna currently has a consensus price target of $46.11, suggesting a potential upside of 35.46%. HUTCHMED has a consensus price target of $23.50, suggesting a potential upside of 33.03%. Given Moderna's higher possible upside, research analysts plainly believe Moderna is more favorable than HUTCHMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moderna 4 Sell rating(s) 17 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.04HUTCHMED 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 SummaryModerna beats HUTCHMED on 8 of the 15 factors compared between the two stocks. Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.08B$3.03B$5.70B$9.52BDividend YieldN/A2.40%4.60%3.99%P/E RatioN/A21.0128.0020.01Price / Sales4.89335.54457.41102.39Price / Cash61.1743.2336.5558.97Price / Book3.998.248.595.87Net Income$37.73M-$55.19M$3.24B$258.50M7 Day Performance0.43%5.35%3.71%1.95%1 Month Performance14.11%17.07%10.26%12.31%1 Year Performance-1.92%4.53%34.07%19.02% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMED2.8149 of 5 stars$17.67-0.6%$23.50+33.0%-5.1%$3.08B$630.20M0.001,811Positive NewsAnalyst ForecastMRNAModerna4.2415 of 5 stars$30.97-0.9%$46.61+50.5%-71.2%$12.09B$3.24B-3.555,800Upcoming EarningsAnalyst ForecastRDYDr. Reddy's Laboratories2.7236 of 5 stars$14.57+0.6%$16.95+16.4%-8.1%$12.09B$3.81B21.9427,811Earnings ReportQGENQIAGEN3.7063 of 5 stars$48.06-0.6%$49.40+2.8%+25.6%$10.75B$1.98B120.495,765Positive NewsAnalyst RevisionVTRSViatris2.3592 of 5 stars$8.90+0.2%$10.40+16.9%-20.1%$10.42B$14.74B-2.8132,000ASNDAscendis Pharma A/S3.4985 of 5 stars$168.02-1.1%$223.07+32.8%+25.6%$10.39B$393.54M-26.751,017Analyst RevisionVRNAVerona Pharma PLC American Depositary Share2.6872 of 5 stars$104.90flat$109.00+3.9%+398.3%$8.93B$42.28M-52.4530Positive NewsBBIOBridgeBio Pharma4.6151 of 5 stars$45.90-1.3%$61.50+34.0%+73.2%$8.83B$221.90M-13.00400BPMCBlueprint Medicines0.972 of 5 stars$129.46flat$128.25-0.9%N/A$8.36B$562.12M-52.41640Upcoming EarningsROIVRoivant Sciences2.6491 of 5 stars$11.48+0.3%$16.50+43.7%+5.9%$7.78B$29.05M-45.92860News CoveragePositive NewsInsider TradeLEGNLegend Biotech3.6854 of 5 stars$42.23+1.5%$73.33+73.7%-25.9%$7.64B$627.24M-71.582,609Positive News Related Companies and Tools Related Companies MRNA Alternatives RDY Alternatives QGEN Alternatives VTRS Alternatives ASND Alternatives VRNA Alternatives BBIO Alternatives BPMC Alternatives ROIV Alternatives LEGN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCM) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
